Diagnostic approach of transthyrretin cardiac amyloidosis in aortic stenosis and heart failure with preserved ejection fraction

被引:0
|
作者
Arana, X. [1 ]
Goena, C. [1 ]
Villanueva, I. [1 ]
Solla, I. [1 ]
Rengel, A. [1 ]
Armengou, A. [2 ]
Garcia-Pavia, P. [3 ]
Gomez, C. [4 ]
Lozano, A. [5 ]
Tojal, L. [6 ]
Basurte, M. [7 ]
Barge, G. [8 ]
Limeres, J. [9 ]
Piqueras, J. [10 ]
Querejeta, R. [1 ]
机构
[1] Donostia Univ Hosp, Osakidetza Basque Hlth Serv, Biodonostia Res Inst, Cardiol, San Sebastian, Spain
[2] Univ Hosp Girona Dr Josep Trueta, Internal Med, Girona, Spain
[3] Puerta de Hierro Majadahonda Univ Hosp, Cardiol, Madrid, Spain
[4] Cruces Univ Hosp, Cardiol, Baracaldo, Spain
[5] Basurto Univ Hosp, Cardiol, Bilbao, Spain
[6] Univ Hosp Araba, Cardiol, Vitoria, Spain
[7] Navarra Univ Hosp, Cardiol, Pamplona, Spain
[8] A Coruna Univ Hosp, Cardiol, La Coruna, Spain
[9] Univ Hosp Vall dHebron, Cardiol, Barcelona, Spain
[10] Univ Gen Hosp Ciudad Real, Cardiol, Ciudad Real, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:36 / 37
页数:2
相关论文
共 50 条
  • [1] Heart failure with preserved ejection fraction in the elderly: when to suspect transthyrretin cardiac amyloidosis?
    Goena, C.
    Arana, X.
    Villanueva, I.
    Solla, I.
    Rengel, A.
    Manas, L.
    Rilo, I.
    Gomez, A.
    Querejeta, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 33 - 33
  • [2] Diagnosing heart failure with preserved ejection fraction in cardiac amyloidosis or diagnosing cardiac amyloidosis in heart failure with preserved ejection fraction?
    Lund, Lars H.
    Eldhagen, Per
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (12) : 2387 - 2389
  • [3] CARDIAC AMYLOIDOSIS: DIAGNOSTIC CHALLENGE IN PATIENTS HAVING HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Darbha, Kaushik
    Douen, Aaron
    Seemungal, Stefan L.
    Hegde, Sudhanva
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 2619 - 2619
  • [4] Heart Failure with Preserved Ejection Fraction and Cardiac Amyloidosis in the Aging Heart
    Tana, Marco
    Piccinini, Rachele
    Moffa, Livia
    Tana, Claudio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [5] Cardiac Amyloidosis. Redefining heart failure with preserved ejection fraction
    Gabilondo, Ivan
    Cartasegna, Luis
    Camilletti, Jorge
    Manganiello, Carlos F.
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2020, 49
  • [6] Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction
    Healy, L.
    Giblin, G.
    Gray, A.
    Starr, N.
    Murphy, L.
    O'Sullivan, D.
    Kavanagh, E.
    Howley, C.
    Tracey, C.
    Morrin, E.
    Mcdaid, A.
    Clarke, A.
    O'Neill, J. O.
    Joyce, E.
    O'Connell, M.
    Mahon, N. G.
    ESC HEART FAILURE, 2025, 12 (02): : 1176 - 1182
  • [7] Cardiac Amyloidosis as a Potential Confounder in Heart Failure With Preserved Ejection Fraction Trials
    Schelbert, Erik B.
    Miller, Christopher A.
    JACC-HEART FAILURE, 2017, 5 (08) : 617 - 617
  • [8] Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction
    Griffin, Jan M.
    Maurer, Mathew S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (01) : 59 - 66
  • [9] Transthyretin Cardiac Amyloidosis in Patients With Acute Heart Failure and Preserved Ejection Fraction
    Horvath, Sofia A.
    Lo Presti, Saberio
    McCloskey, Veronica
    Mihos, Christos G.
    Santana, Orlando
    CIRCULATION, 2018, 138
  • [10] Echocardiographic Patterns of Cardiac Amyloidosis in Patients with Heart Failure with Preserved Ejection Fraction
    Rodriguez-Correa, Carlos
    Bonios, Michael J.
    Conte, Jorge
    Taleb, Iosif
    Wilson, Brent D.
    Gilbert, Edward M.
    Stehlik, Josef
    Drakos, Stavros G.
    Fang, James C.
    Nativi-Nicolau, Jose
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S43 - S44